BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12132141)

  • 1. [Delirium during withdrawal of venlafaxine].
    van Noorden MS; Vergouwen AC; Koerselman GF
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1236-7. PubMed ID: 12132141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Ansseau M
    Rev Med Liege; 1998 Feb; 53(2):106-8. PubMed ID: 9564231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal reactions associated with venlafaxine.
    Parker G; Blennerhassett J
    Aust N Z J Psychiatry; 1998 Apr; 32(2):291-4. PubMed ID: 9588310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Discontinuation of antidepressant serotonergic antidepressant].
    Andersen CL; Videbech P
    Ugeskr Laeger; 2010 Jan; 172(4):296-8. PubMed ID: 20105399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy].
    de Moor RA; Mourad L; ter Haar J; Egberts AC
    Ned Tijdschr Geneeskd; 2003 Jul; 147(28):1370-2. PubMed ID: 12892015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shock-like sensations during venlafaxine withdrawal.
    Reeves RR; Mack JE; Beddingfield JJ
    Pharmacotherapy; 2003 May; 23(5):678-81. PubMed ID: 12741444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Withdrawal reactions associated with low-dose venlafaxine treatment in a patient with premenstrual dysphoric disorder.
    Hsiao MC; Liu CY
    J Clin Psychiatry; 2004 Aug; 65(8):1147-8. PubMed ID: 15323606
    [No Abstract]   [Full Text] [Related]  

  • 9. [Venlafaxine and its discontinuation syndrome].
    Sierra Santos L; Raigal Martín Y; Ortega García A; Barriochoa Martínez de Pisón C; Aparicio Jabalquinto G
    Aten Primaria; 1999 Dec; 24(10):617-8. PubMed ID: 10659465
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of high-dose venlafaxine-related psychosis.
    Dennison EA; Raidoo BM; Cruz R; Raidoo D
    J Clin Psychopharmacol; 2013 Feb; 33(1):134-6. PubMed ID: 23288238
    [No Abstract]   [Full Text] [Related]  

  • 11. [Venlafaxine withdrawal syndrome: report of six cases and review of the literature].
    Pinzani V; Giniès E; Robert L; Peyrière H; Abbar M; Blayac JP
    Rev Med Interne; 2000 Mar; 21(3):282-4. PubMed ID: 10763190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Severe withdrawal symptoms with fever during paroxetine tapering off].
    Peeters FP; Zandbergen J
    Ned Tijdschr Geneeskd; 1999 Jul; 143(27):1429-31. PubMed ID: 10422558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report.
    Hanekamp BB; Zijlstra JG; Tulleken JE; Ligtenberg JJ; van der Werf TS; Hofstra LS
    Neth J Med; 2005 Sep; 63(8):316-8. PubMed ID: 16186642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symptoms of delusion: the effects of discontinuation of low-dose venlafaxine.
    Koga M; Kodaka F; Miyata H; Nakayama K
    Acta Psychiatr Scand; 2009 Oct; 120(4):329-31. PubMed ID: 19573048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine.
    Dallal A; Chouinard G
    J Clin Psychopharmacol; 1998 Aug; 18(4):343-4. PubMed ID: 9690703
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption.
    Shea ML; Garfield LD; Teitelbaum S; Civitelli R; Mulsant BH; Reynolds CF; Dixon D; Doré P; Lenze EJ
    Osteoporos Int; 2013 May; 24(5):1741-9. PubMed ID: 23358607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine and nefazodone, two pharmacologically distinct antidepressants.
    Augustin BG; Cold JA; Jann MW
    Pharmacotherapy; 1997; 17(3):511-30. PubMed ID: 9165554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of premenstrual use of venlafaxine (flexible dose) in the treatment of premenstrual dysphoric disorder.
    Cohen LS; Soares CN; Lyster A; Cassano P; Brandes M; Leblanc GA
    J Clin Psychopharmacol; 2004 Oct; 24(5):540-3. PubMed ID: 15349012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bupropion with SRIs and venlafaxine.
    Spier SA
    Depress Anxiety; 1998; 7(2):73-5. PubMed ID: 9614595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationship with venlafaxine.
    Kelsey JE
    J Clin Psychopharmacol; 1996 Jun; 16(3 Suppl 2):21S-26S; discussion 26S-28S. PubMed ID: 8784645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.